Neurovascular Access Catheters Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Neurovascular Access Catheters Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

During the time frame of the forecast, the neurovascular access catheters market is expected to grow at a CAGR of 4.9%.

COVID-19 had a big effect on the market for neurovascular access catheters because many neurovascular surgeries had to be put off or stopped during the first wave of the pandemic. For example, a February 2021 article in PubMed says that coronavirus affects neurological presentations and health status because neurological patients need to stay in the hospital more often and have a higher risk of death and disability when they get out.Due to the global lockdown, it was hard for patients with neurological problems to get regular checks and treatment, which had a big effect on the market studied.But now that the restrictions have been lifted, the market is likely to grow because neurovascular problems are becoming more common and more people are using neurovascular access catheters.

Market growth is likely to be driven by things like the rise of neurovascular diseases and the improvement of neurovascular catheter technology.For example, according to an article in Frontiers from March 2022, the estimated global incidence of subarachnoid hemorrhage (SAH) is 6.67 per 100,000 people. Each year, SAH affects nearly 500,000 people, and nearly two-thirds of these people live in low- and middle-income countries.Furthermore, technological advances in neurovascular access catheters are expected to drive market growth over the forecast period. For instance, in February 2022, CERENOVUS, an emerging company that focuses on neurovascular care and is part of the Johnson & Johnson Medical Device Companies, launched the EMBOGUARD, a next-generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

Also, research studies and comparisons of the different neurovascular access catheters should help the market grow during the study period. For example, a September 2022 article in PubMed said that a 0.096-inch inner diameter access catheter could be used for neurovascular treatments through both the femoral artery and the radial artery. It had a good rate of technical success and a low rate of problems during the procedure.

So, the studied market is likely to grow over the next few years because neurovascular complications are getting worse, more neurovascular access catheter products are coming out, and more research and development is being done. But problems with biocompatibility are likely to slow market growth for neurovascular access catheters.

A multi-lumen catheter is a single catheter that has multiple internal channels (called lumens). Each lumen can be connected to a distinct intravenous infusion, and the fluid will normally emerge at a slightly different place along the catheter. The multi-lumen catheter market is expected to expand during the forecast period due to factors such as the rising prevalence of neurovascular disorders such as ischemic stroke, stenosis, brain aneurysm, and other illnesses, as well as technological advancements in neurovascular catheters. For instance, as per the Global Stroke Fact Sheet 2022, 12,224,551 cases of ischemic stroke were reported in 2022 across the globe. As per the same source, there are over 12.2 million new strokes each year. Globally, one in four people over age 25 will have a stroke in their lifetime. Hence, the rise in cases of ischemic stroke is anticipated, utilizing the multi-lumen catheter for the treatment and thereby promoting the market growth.

Additionally, an increase in product launches, strategic collaborations, and partnerships by the major players is expected to promote market growth. For example, Zeus Industrial Products added PTFE Sub-Lite-Wall multi-lumen tubing to its line of products in February 2022.It has ultrathin walls, is certified USP Class VI biocompatible, has high structural integrity, improved planarity, high lubricity, and excellent dielectric strength.

Thus, due to the rise in neurovascular complications, increase in multi-lumen catheter product launches, and increase in research and development, the studied segment is anticipated to witness growth over the forecast period.

North America is expected to have a large share of the global market for neurovascular access catheters. This is because neurovascular disorders like ischemic stroke, stenosis, brain aneurysms, and other illnesses are becoming more common, neurovascular catheters are becoming more popular, and the rate of diagnosis is high in this region.

As per the Brain Aneurysm Foundation's 2023 update, an estimated 6.7 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. Hence, the high prevalence of brain aneurysms is likely to increase the adoption of neurovascular access catheters and thereby boost market growth. Furthermore, increasing product launches and the presence of a well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent. For instance, in August 2022, Vena Medical, a developer of neurovascular devices, publicized the successful treatment of the first five patients in the world using the Vena BDAC at the London Health Sciences Centre (LHSC), the University Hospital, and The Ottawa Hospital (TOH). Canada is the first to benefit from the Vena BDAC technology developed right in the patient’s backyard for those requiring mechanical thrombectomy during ischemic stroke treatment. Thrombectomy, a minimally invasive procedure to remove a blood clot, is now the standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a large vessel occlusion.

North America is expected to grow over the next few years because neurovascular diseases are becoming more common, more neurovascular access catheter products are coming out, and more research and development is being done.

The neurovascular access catheters market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Stryker Corporation, Medtronic Plc, Johnson & Johnson, Integer Holdings Corporation, Biomerics, Penumbra, Inc, Zeus Industrial Products, Inc, and Imperative Care Inc are some of the market leaders.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support